In its technical guidelines on safe abortion, the World Health Organization (WHO) states:
Vacuum aspiration and medical abortion are preferred methods for abortion in the first trimester. Both these methods are safe, effective, and suitable for the primary level of care and should also be available at levels of care with greater capacity and in many private clinical settings.
Regrettably, many health facilities still use the sharp curettage, or dilatation and curettage (D&C), method. The WHO guidelines state that because women’s risk of complications is substantially higher with sharp curettage than with vacuum aspiration or medication abortion, this method should be used only when vacuum aspiration and medication abortion are unavailable.
Three methods can be used to safely and effectively terminate pregnancy in the first 12 weeks (84 days) since the woman’s last menstrual period:
- Vacuum aspiration — also called suction abortion, vacuum curettage, suction curettage, menstrual regulation or minisuction — involves removal of the uterine contents by applying suction through a cannula (thin tube) that has been inserted through the cervix. According to the World Health Organization, vacuum aspiration can be used up to 12-15 weeks since the woman’s last menstrual period, depending on the instruments available and the health-care provider’s level of training and skills.
- Medication abortion — also called medical abortion — occurs when pharmacologic agents are administered vaginally or orally to cause expulsion of the uterine contents.
- Sharp curettage — also known as dilatation and curettage (D&C) — involves emptying the uterus by scraping it with curettes (metal instruments). Mechanical dilators are used to open the cervix, and metal curettes are used to scrape the uterine walls. Heavy sedation or general anesthesia is generally required; because of the elevated risk of complications, this method should be used only when vacuum aspiration and medication abortion are unavailable (WHO, 2003).
Several methods are used to induce abortion after 12 weeks (84 days) since the woman’s last menstrual period. The two most widely used methods are dilatation and evacuation (D&E) and medication abortion. The World Health Organization lists both methods as appropriate for terminating pregnancies greater than 12 weeks’ duration.
- Dilatation and evacuation (D&E) is a procedure in which the cervix is dilated and the uterine contents are removed using electric vacuum aspiration. D&E abortion is very safe and effective when performed by trained, experienced providers. D&E is an appropriate technique for the second trimester. It is often used in abortions for pregnancies longer than 12 weeks since the woman’s last menstrual period.
- Medication abortion of pregnancies longer than 12 weeks’ duration — also called medical induction abortion — involves the use of one or more medications to cause uterine contractions that expel the pregnancy, similar to the process of a late miscarriage (spontaneous abortion). Appropriate regimens depend on the duration of the pregnancy and the types of drugs used. Medication abortion protocols used in early abortion are not appropriate for use after 12 weeks since the women’s last menstrual period. One or more of these drugs is typically used for medication abortion after the first 12 weeks: misoprostol, mifepristone, gemeprost. Medications to induce abortion after 12 weeks are most commonly administered orally or vaginally, although other administration routes are possible. Multiple doses are generally required.
- Åhman, Elisabeth and Iqbal Shah. 2002. Unsafe abortion: Worldwide estimates
for 2000. Reproductive Health Matters, 10(19):13-17.
- Bartlett, Linda A., Cynthia J. Berg, Holly B. Shulman, Suzanne B. Zane,
Clarice A. Green, Sara Whitehead and Hani K. Atrash. 2004. Risk factors for
legal induced abortion-related mortality in the United States. Obstetrics
& Gynecology, 103(4):729-737.
- Consensus Statement: Instructions for Use — Abortion Induction with
Misoprostol in Pregnancies through 9 Weeks LMP. Expert Meeting on Misoprostol sponsored by Reproductive
Health Technologies Project and Gynuity Health Projects. July 28, 2003. Washington, DC.
- Coyteaux,
Francine. 2002. Medical abortion: An alternative that increases women’s options.
Mujer Saludhable, Bulletin of the Latin American and Caribbean Women’s
Health Network, September 2002.
- Early options: A provider's guide to medication abortion. Available online.
(Last accessed May 11, 2006.)
- Forna, Fatu and A. Metin Gülmezoglu. 2002. Surgical procedures to evacuate incomplete abortion
(Cochrane Review). In The Cochrane Library, Oxford, Update
Software.
- Goldberg, Alisa B., Gillian Dean, Mi-Suk Kang, Sarah Youssof and Philip
Darney. 2004. Manual versus electric vacuum aspiration for early
first-trimester abortion: A controlled study of complication rates.
Obstetrics & Gynecology, 103(1):101-7.
- Greenslade, Forrest C., Ann H. Leonard, Janie Benson, Judith Winkler and Victoria L.
Henderson. 1993. Manual vacuum aspiration: A summary of clinical and
programmatic experience worldwide. Carrboro, NC, IPAS.
- Herrick, Jeannine, Katherine Turner, Teresa McInerney and Laura Castleman. 2004.
Woman-centered postabortion care: Reference manual. Chapel Hill, NC, Ipas.
- Hyman, Alyson G. and Laura Castleman. 2005. Woman-centered abortion care: Reference manual.
Chapel Hill, NC, Ipas.
- Ipas. 2004. Early abortion with mifepristone and misoprostol.
Clinical Practice Notes. Chapel Hill, NC, Ipas.
- Ipas. 2003. Medical abortion: Implications for Africa. Chapel Hill, NC,
Ipas.
- Ipas. 2004. Misoprostol alone for
first-trimester medical abortion. Clinical Practice Notes. Chapel
Hill, NC, Ipas.
- Johnson, Brooke R., Janie Benson, Janet Bradley and Aurora Rábago Ordoñez. 1993. Costs and
resource utilization for the treatment of incomplete abortion in Kenya and Mexico. Social Science and
Medicine, 36(11):1443-53.
- Magotti, R.F., Phares G.M. Munjinja, Richard S.M. Lema and Edward K.W.
Ngwalle. 1995. Cost effectiveness of managing abortions: Manual vacuum
aspiration (MVA) compared to evacuation by curettage in Tanzania. East
African Medical Journal, 72(4):248-251.
- Planned
Parenthood Federation of America. (Last accessed May 11, 2006.)
- World Health Organization (WHO). 2003. Safe abortion:
Technical and policy guidance for health systems. Geneva, WHO.